DOI: 10.36347/sjmcr.2018.v06i12.003

Pages: 1009-1011

Prolactin is a pleiotropic hormone, in addition to a wide variety of endocrine effects, it has also immunostimulatory effects. As a result, there is increasing evidence linking prolactin to a large number of systemic and organ-specific autoimmune diseases. We describe the case of a 41-years-old woman diagnosed with multiple sclerosis in the context of a prolactinoma with poorly controlled hyperprolactinemia that has been evolving for 5 years. This raises the question of the involvement of prolactin in the pathogenesis of multiple sclerosis.